FTC orders Illumina to divest cancer test maker Grail on competition grounds
April 03, 2023 at 13:39 PM EDT
Illumina acquired Grail in 2021 despite concerns from regulators in the U.S. and Europe. The company will appeal the FTC decision.
Photography by Christophe Tomatis